<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03137277</url>
  </required_header>
  <id_info>
    <org_study_id>PV4343</org_study_id>
    <nct_id>NCT03137277</nct_id>
  </id_info>
  <brief_title>A Study Between Two Instrument Generations to Improve Adenoma Detection in Screening Colonoscopy</brief_title>
  <official_title>A Randomized Comparative Study Between Two Instrument Generations to Improve Adenoma Detection in Screening Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adenoma detection rate (ADR) is the most important parameter to measure outcome quality of
      (screening) colonoscopy. Since single improvements of imaging have not been able to improve
      ADR in many randomized studies, the present study tested the hypothesis that only multiple
      imaging improvements such as seen with two generation changes of colonoscopies - i.e.
      skipping one colonoscope generation - may be necessary before improvements in ADR can be
      measured.

      The investigators will test this hypothesis in the present randomized tandem study in 7
      private practices in Hamburg and Berlin, in a pure screening colonoscopy setting, aiming at
      inclusion of 1200 patients &gt; age of 55 years (screening colonoscopy cut-off in Germany).
      Exclusion criteria are symptomatic patients and colonoscopies planned for therapeutic
      reasons. Main outcome parameter is the ADR (rate of patients with at least one adenoma/all
      patients).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was a prospective multicenter randomized study involving 7 private practice
      gastroenterology offices with a total of 14 experienced examiners (&gt; 2000 colonoscopies),
      performed between November 2013 and September 2016 (sets of instruments were made available
      to 3-4 centers each during 6-12 months).Study population:

      Patients were selected from the screening colonoscopy list (age ≥ 55 years), with further
      inclusion criteria being status 1 and 2 of the ASA classification. After informed consent,
      patients were randomized using sealed envelopes per center to one of either of the two study
      groups

        1. 190 C group (intervention group), examination with the latest generation colonoscope
           (190 series CF or PCF colonoscopies, Olympus Corp, Hamburg, Germany).

        2. 165 C group (control group), examination with the 160/5 generation colonoscope (Olympus
           Corp, Hamburg, Germany), Each patient underwent bowel preparation in accordance with
           local practice of the centers. Bowel cleansing quality was segmentally assessed using a
           modified overall &quot;Boston Bowel Preparation Scale&quot;. Introduction and withdrawal times
           were measured, and times required for biopsies and polypectomies were considered
           separately, i.e. overall and diagnostic only withdrawal times were recorded separately.

      Polyps were documented with regards to location (caecum, ascending, transverse and descending
      colon, sigmoid and rectum), size and morphology using the Paris classification (polypoid
      pedunculated or sessile, non-polypoid slightly elevated/flat/depressed, ulcerous). Polyps
      were then resected using biopsy forceps or cold snare or conventional polypectomy according
      to local standards. Histology of resected polyps was analyzed by local private practice
      specialized GI pathologists according to the Vienna classification with regards to dysplasia
      grade and the presence of serrated adenomas; final histologic categories were hyperplastic,
      adenomatous [tubulous, villous, tubulovillous, serrated (traditional or sessile serrated)].
      Small distal rectal polyps were not systematically biopsied or resected, due to a very high
      likelihood to be hyperplastic.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma detection rate</measure>
    <time_frame>day 1</time_frame>
    <description>adenoma detection rate (ADR) of 190 colonoscopes in comparison to 160/5 colonoscopes at the patient level (% of patients with at least one adenoma).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adenoma rate</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Adenoma rate calculated at the adenoma level (all adenomas/all patients) and as the number of adenomas per adenoma carrier.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenoma subgroups: size</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Adenoma subgroups due to size (&lt; 1 cm, &gt; 1 cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenoma subgroups: form</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Adenoma subgroups due to form (flat, sessile, pedunculated)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenoma subgroups: location</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Adenoma subgroups due to location (right sided - down to left hepatic flexure, left sided - descending colon, sigmoid and rectum)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenoma subgroups: histology</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Adenoma subgroups due to histologic subgroups (SSA, HGIN)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cecal intubation rate</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Cecal intubation rate per arm, all patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication rate</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Complications in both groups</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1221</enrollment>
  <condition>Adenoma Detection Rate</condition>
  <arm_group>
    <arm_group_label>Olympus 190</arm_group_label>
    <description>Olympus colonoscope 190 C (intervention group), screening colonoscopy examination with the latest generation colonoscope (190 series CF or PCF colonoscopies, Olympus Corp, Hamburg, Germany).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Olympus 160/165</arm_group_label>
    <description>Olympus colonoscope 165 C (control group), screening colonoscopy examination with the 160/5 generation colonoscope (Olympus Corp, Hamburg, Germany),</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>screening colonoscopy</intervention_name>
    <description>Introduction and forwarding of the device up to caecum/terminal ileum. Then withdrawal and inspection of colonic wall. Biopsies and polypectomies if necessary. overall and diagnostic (only withdrawal) times being recorded separately.
Polyps are documented with regards to location (caecum, ascending, transverse and descending colon, sigmoid and rectum), size (open forceps or snare for comparison) and morphology using the Paris classification (polypoid pedunculated or sessile, non-polypoid slightly elevated/flat/depressed, ulcerous) Polyps were then resected using biopsy forceps or cold snare (for polyps &lt; 5 mm), or conventional polypectomy according to local standards.</description>
    <arm_group_label>Olympus 190</arm_group_label>
    <arm_group_label>Olympus 160/165</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Colon Polyps and Adenoma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients aged 55 years and above, planned for a screening colonoscopy in one of the
        parttaking private practices.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  screening colonoscopy, age ≥ 55 years

          -  status 1 and 2 of the ASA classification

          -  signed informed consent

        Exclusion Criteria:

          -  Symptoms indicative of colorectal disease such as colonic bleeding, significant
             diarrhea, obstipation and change in bowel habits

          -  Known colonic disease for further evaluation (e.g. inflammatory bowel disease, polyps
             for resection)

          -  Surveillance after polypectomy or colon tumor surgery

          -  Anticoagulants preventing biopsy or polypectomy

          -  Poor general condition (ASA III or more)

          -  Incomplete colonoscopy planned
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Rösch, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Hohenzollerndamm</name>
      <address>
        <city>Berlin</city>
        <zip>10713</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastroenterologie am Bayerischen Platz</name>
      <address>
        <city>Berlin</city>
        <zip>10825</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Mayr / Heller</name>
      <address>
        <city>Berlin</city>
        <zip>12163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Alireza Aminalai</name>
      <address>
        <city>Berlin</city>
        <zip>13437</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Jens Aschenbeck</name>
      <address>
        <city>Berlin</city>
        <zip>13581</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastropraxis Eppendorferbaum</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastroenterologie-Fontanay</name>
      <address>
        <city>Hamburg</city>
        <zip>20354</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med. 2008 Sep 18;359(12):1218-24. doi: 10.1056/NEJMoa0803597. Erratum in: N Engl J Med. 2009 Nov 12;361(20):2004.</citation>
    <PMID>18799558</PMID>
  </reference>
  <reference>
    <citation>Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Sternberg SS, Bond JH, Waye JD, Schapiro M, Panish JF, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med. 1996 Jan 11;334(2):82-7.</citation>
    <PMID>8531963</PMID>
  </reference>
  <reference>
    <citation>von Karsa L, Patnick J, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Executive summary. Endoscopy. 2012 Sep;44 Suppl 3:SE1-8. Epub 2012 Sep 25.</citation>
    <PMID>23012113</PMID>
  </reference>
  <reference>
    <citation>Millan MS, Gross P, Manilich E, Church JM. Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum. 2008 Aug;51(8):1217-20. doi: 10.1007/s10350-008-9315-3. Epub 2008 May 24.</citation>
    <PMID>18500502</PMID>
  </reference>
  <reference>
    <citation>Bretagne JF, Ponchon T. Do we need to embrace adenoma detection rate as the main quality control parameter during colonoscopy? Endoscopy. 2008 Jun;40(6):523-8. doi: 10.1055/s-2007-995786. Epub 2008 May 8.</citation>
    <PMID>18464196</PMID>
  </reference>
  <reference>
    <citation>Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010 May 13;362(19):1795-803. doi: 10.1056/NEJMoa0907667.</citation>
    <PMID>20463339</PMID>
  </reference>
  <reference>
    <citation>Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006 Dec 14;355(24):2533-41.</citation>
    <PMID>17167136</PMID>
  </reference>
  <reference>
    <citation>Bock, J., Toutenburg, H. (1991). Sample size determination in clinical research. In: Rao, C.R., Chakraborty, R. (eds.): Handbook of statistics, Elsevier, 515 - 538.</citation>
  </reference>
  <reference>
    <citation>Adler A, Wegscheider K, Lieberman D, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Mroß M, Scheel M, Schröder A, Gerber K, Stange G, Roll S, Gauger U, Wiedenmann B, Altenhofen L, Rosch T. Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut. 2013 Feb;62(2):236-41. doi: 10.1136/gutjnl-2011-300167. Epub 2012 Mar 22.</citation>
    <PMID>22442161</PMID>
  </reference>
  <reference>
    <citation>Adler A, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Scheel M, Schröder A, Yenerim T, Wiedenmann B, Gauger U, Roll S, Rösch T. Latest generation, wide-angle, high-definition colonoscopes increase adenoma detection rate. Clin Gastroenterol Hepatol. 2012 Feb;10(2):155-9. doi: 10.1016/j.cgh.2011.10.026. Epub 2011 Nov 2.</citation>
    <PMID>22056301</PMID>
  </reference>
  <reference>
    <citation>Adler A, Aschenbeck J, Yenerim T, Mayr M, Aminalai A, Drossel R, Schröder A, Scheel M, Wiedenmann B, Rösch T. Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial. Gastroenterology. 2009 Feb;136(2):410-6.e1; quiz 715. doi: 10.1053/j.gastro.2008.10.022. Epub 2008 Oct 15.</citation>
    <PMID>19014944</PMID>
  </reference>
  <reference>
    <citation>Adler A, Pohl H, Papanikolaou IS, Abou-Rebyeh H, Schachschal G, Veltzke-Schlieker W, Khalifa AC, Setka E, Koch M, Wiedenmann B, Rösch T. A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect? Gut. 2008 Jan;57(1):59-64. Epub 2007 Aug 6.</citation>
    <PMID>17681999</PMID>
  </reference>
  <reference>
    <citation>Adler A, Roll S, Marowski B, Drossel R, Rehs HU, Willich SN, Riese J, Wiedenmann B, Rösch T; Berlin Private-Practice Gastroenterology Working Group. Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1). Dis Colon Rectum. 2007 Oct;50(10):1628-38.</citation>
    <PMID>17694415</PMID>
  </reference>
  <reference>
    <citation>Pohl H, Aschenbeck J, Drossel R, Schröder A, Mayr M, Koch M, Rothe K, Anders M, Voderholzer W, Hoffmann J, Schulz HJ, Liehr RM, Gottschalk U, Wiedenmann B, Rösch T. Endoscopy in Barrett's oesophagus: adherence to standards and neoplasia detection in the community practice versus hospital setting. J Intern Med. 2008 Oct;264(4):370-8. doi: 10.1111/j.1365-2796.2008.01977.x. Epub 2008 May 15.</citation>
    <PMID>18482289</PMID>
  </reference>
  <reference>
    <citation>Meining A, Ott R, Becker I, Hahn S, Mühlen J, Werner M, Höfler H, Classen M, Heldwein W, Rösch T. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance? Gut. 2004 Oct;53(10):1402-7.</citation>
    <PMID>15361485</PMID>
  </reference>
  <reference>
    <citation>Heldwein W, Dollhopf M, Rösch T, Meining A, Schmidtsdorff G, Hasford J, Hermanek P, Burlefinger R, Birkner B, Schmitt W; Munich Gastroenterology Group. The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy. 2005 Nov;37(11):1116-22.</citation>
    <PMID>16281142</PMID>
  </reference>
  <reference>
    <citation>Meining A, Driesnack U, Classen M, Rösch T. Management of gastroesophageal reflux disease in primary care: results of a survey in 2 areas in Germany. Z Gastroenterol. 2002 Jan;40(1):15-20.</citation>
    <PMID>11803496</PMID>
  </reference>
  <reference>
    <citation>Bajbouj M, Reichenberger J, Neu B, Prinz C, Schmid RM, Rösch T, Meining A. A prospective multicenter clinical and endoscopic follow-up study of patients with gastroesophageal reflux disease. Z Gastroenterol. 2005 Dec;43(12):1303-7.</citation>
    <PMID>16315125</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2017</study_first_posted>
  <last_update_submitted>September 4, 2017</last_update_submitted>
  <last_update_submitted_qc>September 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Thomas Rösch</investigator_full_name>
    <investigator_title>Clinic Director of Interdisciplinary Endoscopy Department and Clinic</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>ADR</keyword>
  <keyword>Adenoma detection rate</keyword>
  <keyword>colonoscopic imaging feature improvement</keyword>
  <keyword>Olympus colonoscopes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no individual participant data sharing</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

